Real-time enrollment status for this focal seizure clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:08 PM UTC
| NCT Number | NCT07563881 |
| Recruiting Status | Recruiting |
| Condition | Focal Seizure |
| Phase | PHASE3 |
| Target Enrollment | 333 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Rapport Therapeutics Inc. |
| Last Updated on CT.gov | October 8, 2026 (1 week ago) |
As of October 21, 2026: Clinical trial NCT07563881 is currently recruiting participants. This phase3 study for focal seizure is actively seeking new participants at 14 locations across the United States. The study is sponsored by Rapport Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07563881 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07563881 was last updated 1 week ago (October 8, 2026). HelloStudys verifies this status automatically.